JP2016511238A5 - - Google Patents

Download PDF

Info

Publication number
JP2016511238A5
JP2016511238A5 JP2015556207A JP2015556207A JP2016511238A5 JP 2016511238 A5 JP2016511238 A5 JP 2016511238A5 JP 2015556207 A JP2015556207 A JP 2015556207A JP 2015556207 A JP2015556207 A JP 2015556207A JP 2016511238 A5 JP2016511238 A5 JP 2016511238A5
Authority
JP
Japan
Prior art keywords
albumin
stream
dkp
reaction
feed stream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015556207A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016511238A (ja
JP6387019B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/014478 external-priority patent/WO2014121210A1/en
Publication of JP2016511238A publication Critical patent/JP2016511238A/ja
Publication of JP2016511238A5 publication Critical patent/JP2016511238A5/ja
Application granted granted Critical
Publication of JP6387019B2 publication Critical patent/JP6387019B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015556207A 2013-02-01 2014-02-03 ジケトピペラジンおよびジケトピペラジン含有組成物を生産するための方法 Expired - Fee Related JP6387019B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361759922P 2013-02-01 2013-02-01
US61/759,922 2013-02-01
PCT/US2014/014478 WO2014121210A1 (en) 2013-02-01 2014-02-03 Methods for producing diketopiperazines and compositions containing diketopiperazines

Publications (3)

Publication Number Publication Date
JP2016511238A JP2016511238A (ja) 2016-04-14
JP2016511238A5 true JP2016511238A5 (cg-RX-API-DMAC7.html) 2017-03-09
JP6387019B2 JP6387019B2 (ja) 2018-09-05

Family

ID=51263032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015556207A Expired - Fee Related JP6387019B2 (ja) 2013-02-01 2014-02-03 ジケトピペラジンおよびジケトピペラジン含有組成物を生産するための方法

Country Status (15)

Country Link
US (1) US20150366932A1 (cg-RX-API-DMAC7.html)
EP (1) EP2950811A4 (cg-RX-API-DMAC7.html)
JP (1) JP6387019B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150114984A (cg-RX-API-DMAC7.html)
CN (1) CN105188737A (cg-RX-API-DMAC7.html)
AU (1) AU2014212095B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015017958A2 (cg-RX-API-DMAC7.html)
CA (1) CA2900050A1 (cg-RX-API-DMAC7.html)
EA (1) EA030414B1 (cg-RX-API-DMAC7.html)
HK (1) HK1214772A1 (cg-RX-API-DMAC7.html)
IL (1) IL240125A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015009908A (cg-RX-API-DMAC7.html)
PH (1) PH12015501705A1 (cg-RX-API-DMAC7.html)
SG (2) SG11201505715RA (cg-RX-API-DMAC7.html)
WO (1) WO2014121210A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2381775T3 (es) 2000-08-04 2012-05-31 Dmi Biosciences, Inc. Procedimiento del uso de dicetopiperazinas y composición que las contiene
CN101947306B (zh) 2003-05-15 2014-06-18 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
KR102032400B1 (ko) 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
EP2765968A4 (en) 2011-10-10 2015-01-21 Ampio Pharmaceuticals Inc IMPLANTABLE MEDICINE PRODUCTS WITH INCREASED IMMUNO TOLERANCE AND PROCESSING AND IMPLANTATION METHODS
SG10201605205VA (en) 2011-10-28 2016-08-30 Ampio Pharmaceuticals Inc Treatment of rhinitis
KR20150132508A (ko) 2013-03-15 2015-11-25 앰피오 파마슈티컬스 인코퍼레이티드 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
EP3310375A4 (en) * 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
WO2021016186A1 (en) * 2019-07-19 2021-01-28 University Of Utah Research Foundation Rapid sperm separation based on sperm morphology and motility
WO2021163693A1 (en) * 2020-02-16 2021-08-19 Pur Biologics, Inc. Methods of manufacturing extracellular matrix using aspartyl alanyl diketopiperazine (da-dkp)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE765030A (fr) * 1970-04-02 1971-08-16 Snam Progetti Composes contenant un noyau de dicetopiperazine et leur procedede fabrication
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
US5811241A (en) * 1995-09-13 1998-09-22 Cortech, Inc. Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones
JP2000005569A (ja) * 1998-06-24 2000-01-11 Asahi Chem Ind Co Ltd 直列多段濾過法
ES2381775T3 (es) * 2000-08-04 2012-05-31 Dmi Biosciences, Inc. Procedimiento del uso de dicetopiperazinas y composición que las contiene
CN101279094A (zh) * 2003-05-15 2008-10-08 Dmi生物科学公司 T-细胞介导的疾病的治疗
CN101947306B (zh) * 2003-05-15 2014-06-18 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
US7790039B2 (en) * 2003-11-24 2010-09-07 Northwest Biotherapeutics, Inc. Tangential flow filtration devices and methods for stem cell enrichment
US20050197496A1 (en) * 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
CA2576963C (en) * 2004-08-20 2015-02-17 Prometic Biosciences Ltd. Sequential protein isolation and purification schemes by affinity chromatography
CN102741280B (zh) * 2009-10-30 2015-12-02 诺维信生物制药丹麦公司 白蛋白变体
WO2012174472A1 (en) * 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2765968A4 (en) * 2011-10-10 2015-01-21 Ampio Pharmaceuticals Inc IMPLANTABLE MEDICINE PRODUCTS WITH INCREASED IMMUNO TOLERANCE AND PROCESSING AND IMPLANTATION METHODS
KR102032400B1 (ko) * 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
SG10201605205VA (en) * 2011-10-28 2016-08-30 Ampio Pharmaceuticals Inc Treatment of rhinitis

Similar Documents

Publication Publication Date Title
JP2016511238A5 (cg-RX-API-DMAC7.html)
JP2019504881A5 (cg-RX-API-DMAC7.html)
CN104710525B (zh) 一种金枪鱼鱼骨胶原蛋白源锌螯合胶原肽及其制备方法和用途
EA201500783A1 (ru) Способы получения дикетопиперазинов и соединений, содержащих дикетопиперазины
MX2021012669A (es) Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5- il)-piridin-3-il)metoxi)benzaldehido.
EA201691696A1 (ru) Способы очистки матричной рнк
IL288541B (en) Vaccine against rsv
CN104710511B (zh) 一种源于带鱼鱼肉蛋白的铁螯合肽及其制备方法和用途
CN104745663A (zh) 一种猪血红蛋白综合利用的方法
JP2015500811A5 (cg-RX-API-DMAC7.html)
NZ623576A (en) Tfpi inhibitors and methods of use
RU2017137735A (ru) Фармацевтическая композиция для предотвращения и лечения заболеваний глаз, содержащая в качестве активного ингредиента белок слияния, в котором слиты проникающий в ткань пептид и препарат против фактора роста эндотелия сосудов
RU2019138024A (ru) ХЛОРИДНАЯ СОЛЬ ПЕПТИДА TAT-NR2B9c, КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
JP2020519673A5 (cg-RX-API-DMAC7.html)
JP2018508231A5 (cg-RX-API-DMAC7.html)
WO2014075435A1 (zh) 一种人凝血因子ⅷ的干热处理稳定剂及其用途
CN102552906B (zh) 静注人免疫球蛋白的生产工艺
CN103222537B (zh) 一种双中性蛋白酶分步酶解花生分离蛋白制备花生肽的方法
CN105061558B (zh) 一种金枪鱼蒸煮液活性肽及其制备方法和糖尿病治疗用途
JP2013504519A5 (cg-RX-API-DMAC7.html)
CN104031901B (zh) 一种纯化尿激酶的方法
CN103695513B (zh) 一种提高低分子量大豆肽产量的方法
JP2007535495A5 (cg-RX-API-DMAC7.html)
CN101126105A (zh) 一种用大米分离蛋白制备降血压肽的方法
CN104649920A (zh) 一种门冬氨酸鸟氨酸的制备方法